Stanley Laman Group Ltd. Decreases Stock Holdings in Schrödinger, Inc. (NASDAQ:SDGR)

Stanley Laman Group Ltd. trimmed its position in shares of Schrödinger, Inc. (NASDAQ:SDGR) by 19.3% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 159,469 shares of the company’s stock after selling 38,199 shares during the quarter. Stanley Laman Group Ltd. owned about 0.22% of Schrödinger worth $3,076,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the company. Stephens Investment Management Group LLC lifted its position in shares of Schrödinger by 4.4% during the fourth quarter. Stephens Investment Management Group LLC now owns 1,607,656 shares of the company’s stock valued at $31,012,000 after buying an additional 67,786 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. raised its position in shares of Schrödinger by 60.2% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,510,518 shares of the company’s stock valued at $67,718,000 after purchasing an additional 1,319,464 shares during the last quarter. Redwood Wealth Management Group LLC raised its position in Schrödinger by 8.4% during the 4th quarter. Redwood Wealth Management Group LLC now owns 14,620 shares of the company’s stock worth $283,000 after buying an additional 1,132 shares during the last quarter. KBC Group NV raised its position in Schrödinger by 73.9% during the 4th quarter. KBC Group NV now owns 4,361 shares of the company’s stock worth $84,000 after buying an additional 1,853 shares during the last quarter. Finally, Geneos Wealth Management Inc. grew its stake in shares of Schrödinger by 15.4% during the 4th quarter. Geneos Wealth Management Inc. now owns 59,996 shares of the company’s stock worth $1,157,000 after purchasing an additional 8,021 shares during the period. 79.05% of the stock is owned by hedge funds and other institutional investors.

Schrödinger Trading Down 2.6 %

NASDAQ SDGR opened at $23.86 on Thursday. Schrödinger, Inc. has a 52 week low of $16.67 and a 52 week high of $33.63. The business’s fifty day simple moving average is $21.74 and its 200-day simple moving average is $20.33.

Schrödinger (NASDAQ:SDGR) last posted its earnings results on Tuesday, November 12th. The company reported ($0.52) EPS for the quarter, missing analysts’ consensus estimates of ($0.40) by ($0.12). Schrödinger had a negative net margin of 91.84% and a negative return on equity of 35.77%. The company had revenue of $35.30 million during the quarter, compared to analyst estimates of $41.25 million. During the same period in the previous year, the company earned ($0.86) EPS. The company’s quarterly revenue was down 17.1% compared to the same quarter last year. As a group, sell-side analysts forecast that Schrödinger, Inc. will post -2.37 EPS for the current fiscal year.

Analyst Ratings Changes

SDGR has been the topic of a number of research analyst reports. KeyCorp lifted their price target on shares of Schrödinger from $25.00 to $27.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. BMO Capital Markets lifted their price target on shares of Schrödinger from $25.00 to $28.00 and gave the company an “outperform” rating in a research note on Wednesday, November 13th. Three analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $32.11.

About Schrödinger

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.